DUBLIN, Sept. 7, 2016 /PRNewswire/ -- Jazz
Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company
will be webcasting its corporate presentation at the Morgan Stanley
Global Healthcare Conference in New York,
NY.
Bruce C. Cozadd, chairman and
chief executive officer, will provide an overview of the company
and provide a business and financial update at the conference on
Wednesday, September 14, 2016 at
9:20 a.m. EDT / 2:20 p.m. IST.
A live audio webcast of the presentation may be accessed from
the Investors section of the Jazz Pharmaceuticals website at
www.jazzpharmaceuticals.com. Please connect to the website
prior to the start of the presentation to ensure adequate time for
any software downloads that may be necessary to listen to the
webcast.
An archive of the webcast will be available for at least one
week following the presentation on the Investors section of the
company's website at www.jazzpharmaceuticals.com.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is an international
biopharmaceutical company focused on improving patients' lives by
identifying, developing and commercializing meaningful products
that address unmet medical needs. The company has a diverse
portfolio of products and product candidates, with a focus in the
areas of sleep and hematology/oncology. In these areas, Jazz
Pharmaceuticals markets Xyrem® (sodium oxybate) oral solution,
Erwinaze® (asparaginase Erwinia chrysanthemi) and Defitelio®
(defibrotide sodium) in the U.S. and markets Erwinase® and
Defitelio® (defibrotide) in countries outside the U.S. For more
information, please visit www.jazzpharmaceuticals.com.
Logo - http://photos.prnewswire.com/prnh/20150930/272253LOGO